Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topoproteome analysis of psoriasis during Fumaderm treatment
2010-018517-29Phase 4Completed
- Sponsor
- Medical Faculty Magdeburg
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Fumaderm in plaque psoriasis, sponsored by Medical Faculty Magdeburg. Primary endpoints: Antipsoriatic treatment response at 16 weeks, PASI-50 response rate and 3 more. Started Jan 2010; status: completed.
02
Drugs
Fumaderm
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2010-018517-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018517-29.